Dermata Therapeutics, Inc.
Hedge Funds Holdings

Last updated:

Dermata Therapeutics, Inc.‘s stocks are currently a part of 2 hedge funds’ portfolios, which represents 0.04% of the total amount of its stocks outstanding. This makes up a total of 1.9K shares of Dermata Therapeutics, Inc.. Compared to the previous quarter, the number fell by -99.53% or -402.81K shares fewer. As for the holding position changes, 50% (1) of current holders sold a part of the shares held.

Hedge funds holding Dermata Therapeutics (Q3 2021 – Q1 2023)

Number of hedge funds
Q3 2021 6
Q4 2021 6
Q1 2022 6
Q2 2022 4
Q3 2022 5
Q4 2022 5
Q1 2023 2

Hedge funds changes in Dermata Therapeutics positions (Q3 2021 – Q1 2023)

Changes in positions
Q3 2021 60000
Q4 2021 11112
Q1 2022 11112
Q2 2022 00022
Q3 2022 10103
Q4 2022 10202
Q1 2023 00101

Hedge funds changes in Dermata Therapeutics stock options (Q3 2021 – Q1 2023)

Changes in stock options
Q3 2021 0 0
Q4 2021 305,000 0
Q1 2022 0 0
Q2 2022 0 0
Q3 2022 0 0
Q4 2022 0 0
Q1 2023 0 0

Top 50 hedge fund holders of Dermata Therapeutics, Inc. (NASDAQ:DRMAW)

Hedge fund Value Shares owned Portfolio share
ARMISTICE CAPITAL, LLC 31K 325K 0.001%
EMPERY ASSET MANAGEMENT, LP 17K 175K 0.101%
WARBERG ASSET MANAGEMENT LLC 9K 99.8K 0.002%
BOOTHBAY FUND MANAGEMENT, LLC 6K 12K 0.000%
UBS GROUP AG 1K 9.1K 0.000%